Total Payments
$260,541
2024 Payments
$176,692
Companies
55
Transactions
1,163
Medicare Patients
11,234
Medicare Billing
$1.2M
Payment Breakdown by Category
Research$147,127 (56.5%)
Other$80,012 (30.7%)
Food & Beverage$23,753 (9.1%)
Travel$5,672 (2.2%)
Consulting$3,379 (1.3%)
Education$598.03 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $147,127 | 10 | 56.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $80,012 | 22 | 30.7% |
| Food and Beverage | $23,753 | 1,080 | 9.1% |
| Travel and Lodging | $5,672 | 10 | 2.2% |
| Consulting Fee | $3,379 | 1 | 1.3% |
| Education | $598.03 | 40 | 0.2% |
Payments by Type
Research
$147,127
10 transactions
General
$113,414
1,153 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nielsen BioSciences, Inc. | $137,724 | 1 | $0 (2024) |
| ABBVIE INC. | $55,192 | 218 | $0 (2024) |
| Galderma Laboratories, L.P. | $34,053 | 73 | $0 (2024) |
| SANOFI US SERVICES INC. | $9,403 | 9 | $0 (2020) |
| MERZ NORTH AMERICA, INC. | $4,198 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,030 | 32 | $0 (2024) |
| Allergan, Inc. | $3,503 | 83 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,661 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $1,393 | 94 | $0 (2024) |
| GENZYME CORPORATION | $1,080 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176,692 | 225 | Nielsen BioSciences, Inc. ($137,724) |
| 2023 | $41,751 | 163 | ABBVIE INC. ($30,705) |
| 2022 | $20,766 | 157 | Galderma Laboratories, L.P. ($15,123) |
| 2021 | $3,256 | 126 | MERZ NORTH AMERICA, INC. ($1,231) |
| 2020 | $10,133 | 55 | SANOFI US SERVICES INC. ($9,403) |
| 2019 | $2,683 | 133 | Merz North America, Inc. ($578.22) |
| 2018 | $2,705 | 166 | Merz North America, Inc. ($330.45) |
| 2017 | $2,556 | 138 | Galderma Laboratories, L.P. ($510.25) |
All Payment Transactions
1,163 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/05/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $44.50 | General |
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Dermatology | ||||||
| 11/30/2024 | Nielsen BioSciences, Inc. | Candin (Biological) | — | Cash or cash equivalent | $137,724.30 | Research |
| Study: CFW-3A • Category: Immunotherapy | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/19/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CFW-3A | Nielsen BioSciences, Inc. | $137,724 | 1 |
| Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD) | SANOFI US SERVICES INC. | $6,153 | 6 |
| Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable | SANOFI US SERVICES INC. | $3,250 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,414 | 4,772 | $684,523 | $270,453 |
| 2022 | 29 | 2,844 | 5,056 | $719,755 | $279,658 |
| 2021 | 31 | 2,949 | 5,636 | $612,622 | $308,490 |
| 2020 | 32 | 3,027 | 5,913 | $642,525 | $299,173 |
Total Patients
11,234
Total Services
21,377
Medicare Billing
$1.2M
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 419 | 683 | $122,780 | $60,247 | 49.1% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 14 | 389 | $58,350 | $31,968 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 385 | 483 | $57,760 | $29,046 | 50.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 22 | 61 | $32,635 | $17,550 | 53.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 236 | 297 | $53,460 | $17,506 | 32.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 316 | 438 | $65,385 | $15,306 | 23.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 47 | 50 | $28,000 | $15,020 | 53.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 169 | 194 | $38,470 | $12,653 | 32.9% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 27 | 28 | $18,760 | $9,688 | 51.6% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 22 | 46 | $16,100 | $9,389 | 58.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 29 | 32 | $18,080 | $8,585 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $24,370 | $6,735 | 27.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 71 | 98 | $21,320 | $6,326 | 29.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 253 | 1,435 | $57,055 | $6,309 | 11.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 46 | 57 | $18,240 | $5,175 | 28.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 71 | 129 | $9,675 | $4,337 | 44.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $6,520 | $2,690 | 41.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 17 | 22 | $7,360 | $2,495 | 33.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 20 | 21 | $3,465 | $1,704 | 49.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 15 | 17 | $6,375 | $1,661 | 26.0% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 13 | $4,290 | $1,220 | 28.4% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $4,380 | $1,194 | 27.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 17 | 17 | $2,720 | $1,158 | 42.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 20 | 20 | $2,300 | $779.98 | 33.9% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 11 | 15 | $2,700 | $577.18 | 21.4% |
About Dr. Vlada Groysman, MD
Dr. Vlada Groysman, MD is a Dermatology healthcare provider based in Hoover, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255545455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vlada Groysman, MD has received a total of $260,541 in payments from pharmaceutical and medical device companies, with $176,692 received in 2024. These payments were reported across 1,163 transactions from 55 companies. The most common payment nature is "" ($147,127).
As a Medicare-enrolled provider, Groysman has provided services to 11,234 Medicare beneficiaries, totaling 21,377 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Hoover, AL
- Active Since 05/09/2007
- Last Updated 02/27/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1255545455
Products in Payments
- Candin (Biological) $137,724
- BOTOX (Biological) $29,320
- DUPIXENT (Biological) $10,365
- SKYRIZI (Biological) $1,028
- TREMFYA (Drug) $940.60
- COSENTYX (Biological) $890.81
- EUCRISA (Drug) $825.07
- Xeomin (Biological) $741.50
- ADBRY (Biological) $579.84
- COSENTYX (Drug) $501.59
- Sotyktu (Drug) $493.24
- DUPIXENT (Drug) $468.80
- RINVOQ (Biological) $382.38
- Tremfya (Drug) $381.35
- Humira (Biological) $334.70
- ILUMYA (Biological) $319.22
- TALTZ (Drug) $318.95
- ENSTILAR (Drug) $282.65
- REMICADE (Biological) $276.66
- EPIDUO FORTE (Drug) $270.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Hoover
Dr. Holly Gunn, M.d, M.D
Dermatology — Payments: $34,336
Dermatology $34,336
Katherine Hunt, M.d, M.D
Dermatology — Payments: $10,258
Dermatology $10,258
Elizabeth Martin, M.d, M.D
Dermatology — Payments: $6,558
Dermatology $6,558
Dr. Danette Bentley, M.d, M.D
Dermatology — Payments: $6,283
Dermatology $6,283
Chante Aksut, Md, MD
Dermatology — Payments: $2,622
Dermatology $2,622
Amena Alkeswani
Dermatology — Payments: $691.57
Dermatology $691.57